-
Most Recent
Search Results
240 results for icgn
Take Profits If You Own Ocugen Stock, but Now’s Not the Time to Buy
As Ocugen has a long way to go to get approval from the FDA and commercialize Covaxine, OCGN stock will not likely to reach new…
Read the Label Carefully Before Gambling on Ocugen Stock
OCGN stock has tempted many speculators recently with its high-flying acrobatics. But you’ll want to read the label on Ocugen very carefully before even thinking…
Ocugen Needs Too Much Time and Too Much Cash
OCGN stock has held up despite the failure of what was its flagship drug. The remaining pipeline simply isn’t strong enough for investors to risk…
Ocugen Is a Crisis Trade That Just Might Pan Out
OCGN stock is risky yet the underlying science behind its Covid-19 vaccine combined with a messy situation in the U.S. bodes well.
OCGN Stock Alert: What Is Going on With Red-Hot Ocugen Today?
Investors are in a speculative frenzy around COVAXIN ahead of a WHO meeting tomorrow. OCGN stock is rallying as a result.
Consider Buying Range-Bound Apple Stock Before It Reaches New Highs
Although Apple is one of the consumer technology icons, AAPL stock is likely to be range-bound in the coming weeks.
OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial
OCGN stock fell into the red despite Ocugen’s success in advancing a regenerative cell therapy product evaluation.
Thinking Beyond EVs Will Boost Ford Motor Company Stock
It’s not a reason in and of itself to buy Ford stock, but the Detroit icon is finally thinking proactively about the future.
Google Internet Service Should Scare AT&T and Verizon
Google says it’s not looking to become a threat to wireless icons AT&T and Verizon, but that’s tough to believe.
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.
YHOO Stock: Yahoo! Inc. Is Just Waiting It Out
For all intents and purposes, the once-iconic Yahoo (YHOO) and its shareholders are now just waiting on the inevitable.
Ocugen Stock Is Not One to Trust With Nest Egg Funds
There is too much riding on hope for OCGN stock. It is OK to trade it but fundamental investments are too risky for most.
Make Sure You See Ocugen Stock With Clear Eyes
OCGN stock is a hot trade at this point in 2021. But it’s important for investors to see the company’s outlook clearly.
OCGN Stock: 3 Big Reasons Ocugen Is Rocketing Higher Today
Investors in OCGN stock have a number of catalysts to point to today as reasons to hold onto this outperforming stock.
Icahn Doesn’t Clean Up on Clorox
However, the iconic investor’s failure to bid for Clorox might actually be a bullish sign for the chemical and food giant.
Ocugen Stock Just Needs a Catalyst to Break Free
OCGN stock holders should be patient as the World Health Organization’s potential approval of an important vaccine could happen soon.
Ocugen Will Have Value If Its Covid Vaccine Can Get Approved
OCGN stock could be at a full value today given its revenue prospects but could still rise if its Covaxin vaccine gains approval outside India.
Don’t Get Suckered Into Ocugen Stock
OCGN stock has gone crazy amid a partnership to develop a Covid-19 vaccine. The problem is there’s little evidence it will actually work.
Ocugen Stock Is a Speculative Covid-19 Vaccine Bet
OCGN stock is a speculative bet. FDA approval of Covaxin would boost the shares. However, the firm’s revenue potential is limited.
Ocugen Investors Are Missing the Obvious Signs of Failure
Initially, the stupendous rise of OCGN stock may give you the case of the FOMOs. But don’t let that emotions guide you as Ocugen is…
The Excitement Around Ocugen Is Irrational
OCGN stock surged on news of a coronavirus vaccine, but its fundamentals do not support its stock price, making it another speculative bet.
Ocugen Likely Can’t Get a Boost From the FDA Until 2023
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.
8 – 10 of 240 results
